Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2025Safety and Risk of PharmacotherapyOpen Access

Safety of Post-Infarction Dual Antiplatelet Therapy and Patient Adherence: EMIAS Data Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

СФС. Б. ФитилевИШИ. И. ШкребневаDKD. A. Klyuev

Discussion

Loading...

Member takes

Overview

Retrospective analysis explores adherence to dual antiplatelet therapy and haemorrhagic complications in AMI patients.

Key Points

  • Only 56.5% of patients initially adherent to dual antiplatelet therapy maintained adherence in the second half of the year.
  • The annual incidence of haemorrhagic adverse drug reactions was 24.4%, with higher severity in adherent patients.
  • Retrospective analysis using EMIAS data tracked adherence to therapy and adverse events in patients after acute myocardial infarction.
  • The findings emphasize the need for a personalized approach to balance anti-ischemic benefits and bleeding risks in clinical practice.

Cite This Study

Фитилев et al. (2025) studied this question.

synapsesocial.com/papers/68dc1e3f8a7d58c25ebb20abhttps://doi.org/10.30895/2312-7821-2025-13-3-300-312
View Full Paper
Ask AI
Bookmark
Share